Related Experiment Video
Updated: Jun 18, 2025

Binocular Dynamic Visual Acuity in Eyeglass-Corrected Myopic Patients
Published on: March 29, 2022
Frequency-dependent effects of 0.05% atropine eyedrops on myopia progression and peripheral defocus: a prospective
Yuanfang Yang1, Minsong Xue1, Jiangdong Hao1
1Aier School of Ophthalmology, Central South University, Changsha, 410015, China.
Insights
Low-dose atropine eyedrops slow myopia progression in children. Daily use is most effective, but even weekly use impacts peripheral refraction, with temporal retinal changes linked to slower progression.
Area of Science:
- Ophthalmology
- Pediatric Optometry
- Myopia Control
Background:
- 0.05% atropine eyedrops are effective in slowing myopia progression.
- This study investigates peripheral refraction (PR) in myopic children using 0.05% atropine at varying frequencies.
Purpose of the Study:
- To evaluate the impact of different 0.05% atropine eyedrop frequencies on peripheral refraction in children with myopia.
- To understand the relationship between atropine frequency, myopia progression, and changes in peripheral refractive error.
Main Methods:
- A one-year prospective study involving 138 myopic children randomly assigned to once daily (7/7), twice weekly (2/7), or once weekly (1/7) atropine treatment.
- Measurements included spherical equivalent (SE), axial length (AL), and peripheral refraction (PR) using a Hartmann-Shack wavefront sensor.
- Relative peripheral refraction (RPR) was calculated by subtracting central from peripheral measurements.
Main Results:
- The once-weekly (1/7) group showed significantly greater SE increase and AL elongation compared to daily (7/7) and twice-weekly (2/7) groups.
- The 1/7 group exhibited more myopic PR in the fovea and superior, inferior, and nasal retina, with less myopic RPR peripherally.
- The 7/7 group showed a myopic RPR shift across the entire retina, while the 1/7 group had a hyperopic shift in the superior retina; temporal RPR myopic shift correlated with less myopia progression.
Conclusions:
- Atropine inhibits myopia progression in a frequency-dependent manner, with daily use being most effective.
- While daily atropine (7/7) slowed progression most, it induced more myopic shifts in RPR.
- Relative peripheral refraction in the temporal retina is associated with myopia progression across all treatment groups.
Background:
Atropine, specifically 0.05% eyedrops, has proven effective in slowing myopia progression. This study aims to investigate peripheral refraction (PR) characteristics in myopic children treated with 0.05% atropine eyedrops at different frequencies.
Methods:
One hundred thirty-eight myopic children completed this one-year prospective study, randomly assigned to once daily (7/7), twice per week (2/7), or once per week (1/7) groups. Spherical equivalent (SE) and axial length (AL) were measured. PR was assessed using a custom-made Hartmann-Shack wavefront peripheral sensor, covering a visual field of horizontal 60° and vertical 36°. Relative peripheral refraction (RPR) was calculated by subtracting central from peripheral measurements.
Results:
After one year, SE increased more significantly in the 1/7 group compared to the 7/7 group (P < 0.001) and 2/7 group (P = 0.004); AL elongation was also greater in the 1/7 group compared to the 7/7 group (P < 0.001). In comparison with higher frequency groups, 1/7 group exhibited more myopic PR in the fovea and its vertical superior, inferior, and nasal retina; and less myopic RPR in the periphery retina after one-year (P < 0.05). Additionally, RPR in the 7/7 group demonstrated myopic shift across the entire retina, the 2/7 group in temporal and inferior retina, while the 1/7 group showed a hyperopic shift in the superior retina (P < 0.05). Moreover, myopic shift of RPR in the temporal retina is related to less myopia progression, notably in the 7/7 group (P < 0.05).
Conclusions:
Atropine inhibits myopia progression in a frequency-dependent manner. The once-daily group showed the slowest myopia progression but exhibited more myopic shifts in RPR. Additionally, RPR in the temporal retina was related to myopia progression in all groups.
Trial Registration:
Chinese Clinical Trial Registry, ChiCTR2100043506. Registered 21 February 2021, https://www.chictr.org.cn/showproj.html?proj=122214.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Focusing of Light in the Eye

